Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 2,550 | 0 | 0 | 0 | 0 |
| Gross Profit | 2,550 | N/A | N/A | N/A | N/A |
| Operating Expenses | 27,570 | 25,311 | 23,292 | 24,125 | 21,453 |
| Operating Income | -25,020 | -23,040 | -23,292 | -24,125 | -21,453 |
| Other Income | 1,633 | 1,944 | 2,284 | 2,329 | 1,913 |
| Pre-tax Income | -23,387 | -21,096 | -21,008 | -21,796 | -19,540 |
| Income Tax | N/A | 103 | -9 | 30 | 17 |
| Net Income Continuous | -23,387 | -21,199 | -20,999 | -21,826 | -19,557 |
| Net Income | $-23,387 | $-21,199 | $-20,999 | $-21,826 | $-19,557 |
| EPS Basic Total Ops | -2.49 | -2.24 | -2.26 | -2.43 | -2.44 |
| EPS Basic Continuous Ops | -2.49 | -2.24 | -2.26 | -2.43 | -2.44 |
| EPS Diluted Total Ops | -2.49 | -2.24 | -2.26 | -2.43 | -2.44 |
| EPS Diluted Continuous Ops | -2.49 | -2.24 | -2.26 | -2.43 | -2.44 |
| EPS Diluted Before Non-Recurring Items | -2.49 | -2.26 | -2.26 | N/A | N/A |
| EBITDA(a) | $-24,135 | $-24,681 | $-23,415 | $-23,575 | $-20,727 |